-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Outlook Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q4 2018 to Q2 2024.
- Outlook Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.4M, a 1.05% increase year-over-year.
- Outlook Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $5.37M, a 2.98% decline year-over-year.
- Outlook Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.55M, a 28.1% decline from 2022.
- Outlook Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.71M, a 57.8% increase from 2021.
- Outlook Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.89M, a 74.1% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)